Ghisallo Capital Management LLC Takes Position in Oaktree Acquisition Corp. III Life Sciences $OACC

Key Points

• Ghisallo Capital Management LLC has acquired a $4.59 million stake in Oaktree Acquisition Corp. III Life Sciences, purchasing 450,000 shares which represent about 2.01% of the company.
• Several institutional investors, including Picton Mahoney Asset Management and Mizuho Securities USA LLC, have also recently invested in Oaktree Acquisition Corp. III Life Sciences, indicating growing interest in the company.
• Oaktree Acquisition Corp. III Life Sciences is a blank check company, established for the purpose of engaging in mergers, acquisitions, or similar business combinations, and is headquartered in Los Angeles, CA.

Ghisallo Capital Management LLC purchased a new stake in shares of Oaktree Acquisition Corp. III Life Sciences (NASDAQ:OACC - Free Report) in the 1st quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor purchased 450,000 shares of the company's stock, valued at approximately $4,590,000. Ghisallo Capital Management LLC owned 2.01% of Oaktree Acquisition Corp. III Life Sciences as of its most recent SEC filing.

A number of other institutional investors also recently modified their holdings of the company. Toronto Dominion Bank purchased a new stake in Oaktree Acquisition Corp. III Life Sciences in the fourth quarter worth about $14,355,000. Driehaus Capital Management LLC bought a new stake in shares of Oaktree Acquisition Corp. III Life Sciences during the first quarter valued at approximately $9,180,000. Linden Advisors LP bought a new stake in shares of Oaktree Acquisition Corp. III Life Sciences during the first quarter valued at approximately $6,120,000. Two Sigma Investments LP bought a new stake in Oaktree Acquisition Corp. III Life Sciences in the 4th quarter worth approximately $4,358,000. Finally, Lighthouse Investment Partners LLC bought a new stake in Oaktree Acquisition Corp. III Life Sciences in the 4th quarter worth approximately $3,039,000.

Oaktree Acquisition Corp. III Life Sciences Trading Down 0.2%

Shares of Oaktree Acquisition Corp. III Life Sciences stock traded down $0.02 on Thursday, hitting $10.44. 440 shares of the company's stock were exchanged, compared to its average volume of 100,996. Oaktree Acquisition Corp. III Life Sciences has a 1 year low of $9.95 and a 1 year high of $10.85. The company has a 50-day simple moving average of $10.44 and a 200-day simple moving average of $10.33.

About Oaktree Acquisition Corp. III Life Sciences

Oaktree Acquisition Corp. III Life Sciences is a blank check company, which was created for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was founded in 1995 and is headquartered in Los Angeles, CA.